H.Z. Turna
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 7
- Lung Cancer Research Studies 1
- Global Cancer Incidence and Screening 1
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Tony Mok (7 shared papers)Gilberto de Castro (7 shared papers)Byoung Chul Cho (7 shared papers)Dariusz M. Kowalski (7 shared papers)Yi‐Long Wu (6 shared papers)Gilberto Lopes (4 shared papers)Iveta Kudaba (4 shared papers)К. К. Лактионов (4 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Journal of Thoracic Oncology (1 paper)Indian Journal of Surgery (1 paper)
- Partner nations
- TürkiyeBrazilSouth Korea
In The Last Decade
H.Z. Turna
8 papers receiving 383 citations
H.Z. Turna's Hit Papers
Peers
Comparison fields: 5 of 30
- Oncology 272
- Pulmonary and Respiratory Medicine 160
- Cancer Research 34
- Immunology 44
- Pathology and Forensic Medicine 12
Countries citing papers authored by H.Z. Turna
This map shows the geographic impact of H.Z. Turna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.Z. Turna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.Z. Turna more than expected).
Fields of papers citing papers by H.Z. Turna
This network shows the impact of papers produced by H.Z. Turna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.Z. Turna. The network helps show where H.Z. Turna may publish in the future.
Co-authors
The 25 scholars most cited alongside H.Z. Turna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study Hit paper breakdown → | 2022 | 169 |
| 2 | 2019 | 79 | |
| 3 | 2023 | 42 | |
| 4 | 2020 | 32 | |
| 5 | 2019 | 32 | |
| 6 | 2021 | 21 | |
| 7 | 2021 | 12 | |
| 8 | 2019 | 1 |
About H.Z. Turna
H.Z. Turna is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Infectious Diseases, having authored 8 papers that have together received 388 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (1 paper), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Global Cancer Incidence and Screening (1 paper) and Breast Lesions and Carcinomas (1 paper). The work is most often cited by research in Oncology (272 citations), Pulmonary and Respiratory Medicine (160 citations), Cancer Research (34 citations), Immunology (44 citations) and Pathology and Forensic Medicine (12 citations). H.Z. Turna has collaborated with scholars based in Türkiye, Brazil and South Korea. Frequent co-authors include Tony Mok, Gilberto de Castro, Byoung Chul Cho, Dariusz M. Kowalski, Yi‐Long Wu, Gilberto Lopes, Iveta Kudaba, К. К. Лактионов, Bogusława Karaszewska and Christian Caglevic. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, Journal of Thoracic Oncology and Indian Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.